Biotech

All Articles

BioAge eyes $180M coming from IPO, personal placement for obesity trials

.BioAge Labs is actually looking at about $180 million in first earnings from an IPO and a personal ...

Merck's LAG-3 combo stops working colorectal cancer cells phase 3 research study

.An attempt by Merck &amp Co. to uncover the microsatellite dependable (MSS) metastatic colon cancer...

Spanish VC finalizes $200M life sciences fund

.Spain-based Asabys Allies has shut a fund of 180 million europeans ($ 200 million), amount of money...

BioAge produces $198M coming from IPO as excessive weight biotech joins Nasdaq

.BioAge Labs is generating almost $200 million by means of its own Nasdaq IPO this morning, along wi...

Acadia carries BMS vet on board as chief executive officer-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our roundup of notable leadership hirings, shootings and ...

Cassava pays $40M over supposedly misleading Alzheimer's upgrade

.Cassava Sciences has accepted to spend $40 million to deal with an inspection in to insurance claim...

Merck bags options on Evaxion's AI-designed injection applicants

.Merck &amp Co. has actually picked up choices on pair of Evaxion Biotech vaccination prospects, spe...

Enanta's RSV antiviral crushes viral tons in challenge study

.Enanta Pharmaceuticals has linked its breathing syncytial infection (RSV) antiviral to substantial ...

Biogen canisters SAGE-324 cooperation after essential shake neglect

.Biogen has actually administered the final rites to its own cooperation with Sage Therapies on SAGE...

AbbVie Parkinson's medication coming from $8.7 B Cerevel buyout scores

.On the exact same time that some Parkinson's health condition medicines are being actually brought ...